| Date | Name | Title | Type | Shares Traded | Price Range | |||
|---|---|---|---|---|---|---|---|---|
| May 17, 2010 | goldstein joseph l | Director | Sell | 400 | 28.06 | |||
| May 14, 2010 | goldstein joseph l | Director | Disposition (Non Open Market) | 4,600 | 27.63 | |||
| May 14, 2010 | goldstein joseph l | Director | Option Execute | 5,000 | 25.43 | |||
| May 14, 2010 | vagelos p roy | Director | Sell | 20,000 | 26.96 - 27.19 | |||
| May 13, 2010 | shooter eric m | Director | Option Execute | 5,000 | 25.43 | |||
| Apr 12, 2010 | vagelos p roy | Director | Disposition (Non Open Market) | 7,952 | n/a | |||
| Apr 9, 2010 | brown michael s | Director | Acquisition (Non Open Market) | 29,662 | n/a | |||
| Mar 22, 2010 | aberman michael s | Officer | Acquisition (Non Open Market) | 10,000 | n/a | |||
| Feb 17, 2010 | shooter eric m | Director | Automatic Sell | 15,000 | 30.00 | |||
| Feb 17, 2010 | shooter eric m | Director | Option Execute | 15,000 | 18.80 | |||
| Feb 4, 2010 | goldberg murray a | Officer | Automatic Sell | 6,105 | 26.45 - 28.38 | |||
| Feb 4, 2010 | roberts william | Officer | Automatic Sell | 514 | 27.48 - 28.38 | |||
| Feb 3, 2010 | goldberg murray a | Officer | Automatic Sell | 13,895 | 28.02 | |||
| Feb 3, 2010 | goldberg murray a | Officer | Option Execute | 20,000 | 9.49 - 13.00 | |||
| Feb 3, 2010 | kolinski stuart | Officer | Automatic Sell | 5,401 | 27.66 - 28.08 | |||
| Feb 3, 2010 | roberts william | Officer | Automatic Sell | 3,315 | 27.66 - 28.08 | |||
| Feb 3, 2010 | roberts william | Officer | Option Execute | 1,500 | 13.00 | |||
| Feb 2, 2010 | kolinski stuart | Officer | Automatic Sell | 6,913 | 27.16 | |||
| Feb 2, 2010 | kolinski stuart | Officer | Option Execute | 12,314 | 8.50 | |||
| Feb 2, 2010 | mccorkle douglas s | Officer | Automatic Sell | 5,875 | 28.00 | |||
| ||||||||
Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
| NASDAQ:REGN
$24.60 + 0.18 |
Sep 9, 2010
4:00 PM ET |
Quotes delay at least 20min., by eSignal.
